Response to endothelin-1 in arteries from human colorectal tumours: Role of endothelin receptors

Experimental Biology and Medicine

Volumn 233, Issue 12, 2008, Pages 1602-1607

  Ferrero, Eduardo ^a   Labalde, Maria ^a   Fernandez, Nuria ^b   Monge, Luis ^b   Salcedo, Adely ^b   Narvaez Sanchez, Raul ^b   Hidalgo, Manuel ^a   Dieguez, Godofredo ^b   García Villalon, Angel Luis ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Endothelin ETb receptors; Nitric oxide; Prostaglandins

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BRADYKININ; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; MECLOFENAMIC ACID; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE METHYL ESTER; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; VASOCONSTRICTOR AGENT;

ANTINEOPLASTIC ACTIVITY; ARTERIAL CIRCULATION; ARTICLE; BLOOD FLOW; COLON; COLORECTAL TUMOR; HISTOPATHOLOGY; HUMAN; MESENTERIC ARTERY; VASOCONSTRICTION; VASODILATATION; AGED; ARTERY; CASE CONTROL STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

CITRUS MACROPHYLLA;

AGED; ARTERIES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; FEMALE; HUMANS; MALE; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 58749086092     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0802-RM-69     Document Type: Article

References (23)

1. Yaegashi H, Takahashi T. Encasement and other deformations of tumour-embedded host arteries due to loss of medial smooth muscles. Morphometric and three-dimensional reconstruction studies on some human carcinomas. Cancer 65:1097-1103, 1990.
2. Suzuki M, Takahashi T, Sato T. Medial regression and its functional significance in tumour-supplying host arteries. A morphometric study of hepatic arteries in human livers with hepatocellular carcinoma. Cancer 59:444-450, 1987.
3. Suzuki M, Hori K, Saito S, Tanda S, Abe I, Sato H, Sato H. Functional characteristics of tumour vessels: selective increase in tumour blood flow. Sci Rep Res Inst Tohoku Univ 36:37-45, 1989.
4. Nomura T, Ikezaki K, Natori Y, Fukui M. Altered response to histamine in brain tumour vessels: the selective increase of regional cerebral blood flow in transplanted rat brain tumour. J Neurosurg 79:722-728, 1993.
5. Morissette G, Petitclerc E, Marceau F. Loss of function of vascular smooth muscle cells by nitric oxide-dependent and -independent interactions with tumourigenic cells. Int J Cancer 112:830-839, 2004.
6. Tozer GM, Prise VE, Bell KM, Dennis MF, Stratford MR, Chaplin DJ. Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification. Br J Cancer 74:1955-1960, 1996.
7. Arun C, London NJ, Hemingway DM. Prognostic significance of elevated endothelin-1 levels in patients with colorectal cancer. Int J Biol Markers 19:32-37, 2004.
8. B receptors in anesthetized rats. Int J Cancer 73:283-289, 1997.
9. Soveaux P, Dessy C, Martinive P, Havaux X, Jordan BF, Gallez B, Gregoire V, Balligand JL, Feron O. Endothelin-1 is a critical mediator of myogenic tone in tumour arterioles: implications for cancer treatment. J Cancer Res 64:3209-3214, 2004.
10. Martínez MA, Fernández N, García-Villalcón AL, Monge L, Diéguez G.Comparison of the in vivo coronary action of endothelin-1 and vasopressin. Role of nitric oxide and prostanoids. Vascul Pharmacol 40:247-252, 2004.
11. Climent B, Fernández N, Sanz E, Sánchez A, Monge L, García-Villalón AL, Diéguez G. Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion. Role of endothelin receptors, nitric oxide and prostanoids. Eur J Pharmacol 524:102-110, 2005.
12. Miyauchi T, Tomobe Y, Ishikawa T, Goto K, Sugishita Y. Vaso-constriction by endothelin-1 in resistance and conduit portions of isolated human mesenteric arteries. Eur J Pharmacol 303:193-196,1996.
13. Deng LY, Schiffrin EL. Calcium dependence of effects of endothelin on rat mesenteric microvessels. Can J Physiol Pharmacol 69:798-804,1991.
14. Tanoi C, Suzuki Y, Shibuya M, Sugita K, Masuzawa-Ito K, Asano M. Comparison of vasoconstrictor actions of endothelin-1 in cerebral, coronary, and mesenteric arteries of the dog. J Cardiovasc Pharmacol 19:568-579, 1992.
15. B receptor agonist IRL 1620. Int J Cancer 80:295-302,1999.
16. White LR, Leseth KH, Moller S, Juul R, Adner M, Cappelen J, Bovim G, Aasly J, Edvinsson L. Interleukin-1 beta potentiates endothelin ET(B) receptor-mediated contraction in cultured segments of human temporal artery. Regul Pept 31:89-95, 1999.
17. B receptor contractile activity in rat cerebral artery. Neuroreport 10:2355-2359, 1999.
18. Udman E, Moller S, Adner M, Edvinsson L. Cytokines induce increased endothelin ET(B) receptor-mediated contraction. Eur J Pharmacol 376:223-232, 1999.
19. Yan L, Anderson GM, DeWitte M, Nakada MT. Therapeutic potential of cytokine and chemokine antagonists in cancer therapy. Eur J Cancer 42:793-802, 2006.
20. B receptors in rat isolated small mesenteric arteries. Br J Pharmacol 120:1376-1382,1997.
21. Adner M, Cantera L, Ehlert F, Nilsson L, Edvinsson L. Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Br J Pharmacol 119:1159-1166, 1996.
22. Ali H, Dashwood M, Dawas K, Loizidou M, Savage F, Taylor I. Endothelin receptor expression in colorectal cancer. J Cardiovasc Pharmacol 36:S69-S71, 2000.
23. Tozer GM, Prise VE, Chaplin DJ. Inhibition of nitric oxide synthase induces a selective reduction in tumour blood flow that is reversible with L-arginine. Cancer Res 57:948-955, 1997.